Metraipolis › archive › dc_ef76a60050c5

Equity and budget challenges associated with the employment of anti-amyloid monoclonal antibodies for early Alzheimer's Disease in Italy: A scenario analysis — Europe PMC PMID:42306480

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306480
DOI
10.1016/j.jarlif.2026.100076
License (as archived)
solo-consultazione
Archived
2026-10-31T19:28:57.978Z
SHA-256 of the archived text
1f0bb75f2f388d0461f3f18d7b63a2c611a21e86142b50c1f1b5bda5fce41044
Stable URL of this page
https://metraipolis.com/documento/dc_ef76a60050c5

How to cite

Equity and budget challenges associated with the employment of anti-amyloid monoclonal antibodies for early Alzheimer's Disease in Italy: A scenario analysis — Europe PMC PMID:42306480 — Europe PMC (en), https://europepmc.org/article/MED/42306480 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef76a60050c5 (Metraipolis archive dc_ef76a60050c5, sha256 1f0bb75f2f388d0461f3f18d7b63a2c611a21e86142b50c1f1b5bda5fce41044)
BibTeX
@misc{dcef76a60050c5,
  title = {Equity and budget challenges associated with the employment of anti-amyloid monoclonal antibodies for early Alzheimer's Disease in Italy: A scenario analysis — Europe PMC PMID:42306480},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306480},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef76a60050c5; sha256 1f0bb75f2f388d0461f3f18d7b63a2c611a21e86142b50c1f1b5bda5fce41044},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306480. Agents can read the archived copy with the MCP tool read_document.